In extracavernosal vascular tissue, smooth muscle tone is modulated by a balance between angiotensin II (Ang II) and nitric oxide (NO). We hypothesized that these substances also play an important role in regulating cavernosal smooth muscle contractility. We therefore studied the in vitro effects of an Ang II receptor antagonist and a nitric oxide synthase (NOS) inhibitor on the contractile effects of Ang II, phenylephrine, and electrical ®eld stimulation in canine corpus cavernosum. Ang II caused a dose-dependent contraction of cavernosal smooth muscle which was inhibited by the Ang II receptor antagonist and augmented by NOS inhibition. Contractions induced by phenylephrine or electrical stimulation were diminished by the Ang II receptor antagonist, and augmented by NOS inhibition. We conclude that Ang II plays an important role in modulating cavernosal smooth muscle tone, and that the contractile effect of Ang II on cavernosal tissue is modulated by the local NO environment.
Introduction
The tone of the cavernosal smooth muscle plays an important role in erectile function. 1 However, modulation of the tone and contractility of cavernosal smooth muscle is a complex process. Since the density of nerve terminals is not suf®cient to support a synchronous contraction and relaxation of all the smooth muscle cells, the actions of neurotransmitters and neuropeptides such as acetylcholine, 2 catecholamines, 3 nitric oxide, 4 vasoactive intestinal peptide (VIP), 5 calcitonin gene related peptide (CGRP), 6 and neuropeptide Y, 7 are complemented by locally produced paracrine regulators. Cavernosal endothelial cells produce and release a range of synergistic and antagonistic regulators such as prostanoids, 8 endothelin-1, 9 and nitric oxide. Recent evidence suggests that angiotensin II (Ang II) may also modulate cavernosal smooth muscle tone and contractility. We observed that human and animal corpus cavernosum produces and secretes physiologically relevant amount of Ang II. 10, 11 Moreover, the participation of locally produced Ang II in the modulation of erectile function is supported by the observation that intracavernosal injection of Ang II receptor antagonists increased cavernosal pressure to the level of mean arterial pressure in a dose dependent manner in anesthetized dogs. 10, 12 In extracavernosal vascular tissue, a balance between Ang II and NO modulates smooth muscle tone, thereby regulating regional blood¯ow.
13±15
These vasoactive substances mediate opposing actions, with NO causing a decrease and Ang II mediating an increase in smooth muscle tone. We hypothesized that a similar relationship between Ang II and NO exists in the corpus cavernosum. We therefore studied the effects of Ang II, Ang II receptor antagonists, and nitric oxide synthase (NOS) inhibiters on the contractility of canine cavernosal tissue in vitro. The goals of this study were to evaluate the ability of Ang II to modulate cavernosal smooth muscle contraction, to examine the modulatory effects of Ang II receptor antagonists on electrically and andrenergically mediated contractions of canine cavernosal smooth muscle, and to assess whether these processes were affected by an alteration in local NO levels.
4.7 mM KCl, 1.2 mM MgCl 2 , 1.2 mM NaH 2 PO 4 , 2.5 mM CaCl 2 , 25 mM NaHCO 3 and 11 mM glucose). After carefully removing the tunica albuginea from the corpus cavernosum, smooth muscle strips (approximately 4 6 7 mm) were suspended in organ baths containing 50 ml Krebs' solution at 37 C, which was continuously bubbled with a mixture of 95% oxygen and 5% carbon dioxide. One end of the tissue strip was tied with silk and connected to a force transducer, while the other end was connected to a ®xed metal prong on an electrode support, so that the tissue strip was suspended between two platinum plates. Changes in muscle tension were recorded on a Gould Brush 2400 chart recorder. The cavernosal tissue strips were subjected to a resting tension of 1.0 mN and allowed to equilibrate for at least 30 min. Reagents were added in a volume of less than 1/100 total bath volume. All concentrations of reagents reported are bath concentrations.
Electric ®eld stimulation
Electric ®eld stimulation (EFS) was delivered by a Harvard Stimulator using 40 V for 10 s, with a pulse duration of 5 ms. Recovery time between stimuli was at least 2 min to assure the return to resting tension. Frequency-response curves were generated at frequencies of 1±64 Hz.
Phenylephrine stimulation
Muscle strips were contracted with 2 6 10 75 M L-phenylephrine hydrochloride (PE). EFS was performed at maximum tension using a ®xed frequency of 5 Hz.
Effect of angiotensin II
A dose-response curve to human angiotension II (Ang II: Peninsula Laboratories, Inc.) was determined by adding 10 79 to 10 75 M Ang II to the muscle baths. Tension changes in the strips were observed until maximum response. EFS was performed at the time of maximum tension on the Ang II contracted strips at a ®xed frequency of 5 Hz. In two instances, a 10 75 M solution of sodium nitroprusside dihydrate (Sigma), a nitric oxide donor, was added to the baths at the peak of contraction.
Effect of Ang II receptor antagonists
After washing the cavernosal tissue strips twice with 50 ml Krebs' solution at 37 C, they were allowed to re-equilibrate at approximately 1.0 mN resting tension for 15 min. The effect of the Ang II receptor antagonist, losartan (Merck), on the response to ®eld stimulation, PE, and Ang II were studied in three separate experiments. Thirty minutes after the addition of 5 6 10 74 M losartan to the organ baths: (1) a frequency-response curve to EFS was determined; (2) 2 6 10 75 M PE was added; or (3) Ang II was added (10 78 to 10 75 M), followed by EFS (5 Hz) at the time of maximum contraction tension.
Effect of NOS inhibitor
The effect of L-N G -nitroarginine methyl ester (L-NAME: Biol) was tested by adding 5 6 10 74 M of the nitric oxide synthase (NOS) inhibitor to half of the baths containing cavernosal strips. After thirty minutes: (1) a frequency-response curve to EFS was determined; (2) 2 6 10 75 M PE was added; or (3) Ang II was added (10 78 to 10 75 M), followed by EFS (5 Hz) at the time of maximum contraction tension.
Statistical methods
Differences in mean contraction tension (measured as percent over baseline) were assessed using the Wilcoxon rank-sum test. P`0.05 was considered statistically signi®cant.
Results
By the end of the equilibration period, none of the canine corpus cavernosal strips displayed oscillating spontaneous activity. A mean tension of 0.95 AE 0.08 mN was maintained (n 22 strips, from N 10 dogs). Contractions are reported as percent increase over resting tension, and relaxations are reported as percent decrease from maximum contraction tension.
Effects of EFS and PE administration
EFS induced transient contractions that increased with higher frequencies, up to 32 Hz. Maximum contraction tension occurred at 32 Hz, and averaged 34 AE 9.5% above baseline tension. Addition of 2 6 10 75 M PE solution resulted in a mean increase in tension of 51 AE 19% (n 10). In strips precontracted with 2 6 10 75 M PE, EFS (5 Hz) caused transient relaxations with a mean reduction in tension of 18 AE 8.6% (Figure 1) .
Effects of Ang II
In the cavernosal strips, exposure to Ang II caused a dose-dependent increase in tension. Maximal contraction (at 32 Hz) was diminished from a mean tension of 34 AE 9.5% to 16 AE 5.2% above baseline (median tension decreased from 30% to 18%, P 0.007). Losartan also reduced the contractile effects of PE (Figure 6a ), diminishing mean maximal tension from 51 AE 19% to 19 AE 10% above baseline (median tension decreased from 49% to 21%, P 0.002). Losartan completely inhibited the response of the cavernosal strips to Ang II (Figure 3b ).
Effects of NOS inhibitor

Addition of 5 6 10
74 M L-NAME did not affect the resting tension of the cavernosal tissue strips, but augmented the contractile response to EFS at all frequencies ( Figure 5 ). At 32 Hz, peak contraction increased from a mean of 34 AE 9.5% to 68 AE 5.5% above baseline (median tension increased from 30% to 65%, P 0.02). PE-induced peak contraction increased from a mean of 51 AE 19% to 111 AE 64% above baseline (median tension increased from 49% to 104%, P 10, Figure 6b ) Thirty minutes after exposure to L-NAME, mean maximum contraction following addition of 10 77 M Ang II increased from 5.2 AE 7.8% to 21 AE 17% over baseline (median tension increased from 2.1% to 27%, P 0.03). With 10 76 M Ang II, peak contraction increased from 14 AE 8.2% to 57 AE 36% over baseline (median increased from 13% to 43%, P`0.0001), and with 10 75 M Ang II, maximum tension increased from 26 AE 14% to 53 AE 32% over baseline (median tension increased from 28% to 46%, P 0.07). Figure 2 illustrates the effects of the NOS inhibitor on Ang II response. In these strips EFS (5 Hz) induced further contraction (mean 34 AE 38% increase in tension, n 7, Figure 4b ). 
Discussion
In this study we have demonstrated that Ang II causes a dose-dependent contraction of canine corpus cavernosum strips with addition of Ang II in concentrations as low as 10 77 M. This contractile response was augmented by pre-treatment of the muscle strips with the nitric oxide synthase inhibitor, L-NAME. Such ampli®ed reactivity is in agreement with previous reports that inhibition of NO generation causes an exaggerated Ang II pressor response in rat vascular smooth muscle. 16, 17, 19 We also observed that the Ang II contraction was readily abolished by addition of the NO donor sodium nitroprusside. Moreover, electrical stimulation of the Ang II contracted cavernosal tissue resulted in a decrease in tension, by an average of 11%. When pre-treated with a NOS inhibitor, EFS caused further contraction of these Ang II contracted strips. Thus, EFS induces the release of mediators of both smooth muscle dilation and contraction. NOS inhibition appears to tilt the balance toward smooth muscle contraction. Our results suggest that NO negatively in¯uences the effects of Ang II in cavernosal smooth muscle, as is the case in extracavernosal vascular tissue.
Although in vitro observations alone may not establish a physiological role for Ang II in erectile function in vivo, the inhibition of both the EFS and PE mediated cavernosal smooth muscle contractions by losartan suggests that electric ®eld and adrenergic stimulation may indeed involve Ang II. While it has been shown that modulation of adrenergic activity is one of the most important means by which the contractile state of the smooth muscle of the corpus cavernosum is in¯uenced, 3 our results suggest that this adrenergic in¯uence involves Ang II as a mediator of smooth muscle contraction. Our hypothesis that Ang II plays an important role in corpus cavernosal smooth muscle contraction is supported, not only by this in vitro data, but also by previous demonstrations that human cavernosal tissue produces and secretes physiologically relevant amounts of Ang II, 11 and that intracavernosal administration of Ang II induces a potent contraction of erectile tissue in dogs. 10, 12 It has recently been shown that the modulation of regional blood¯ow in vascular tissues depends in part on a balance between NO and Ang II, and that an imbalance between these substances can result in hypertension. 18, 19 Administration of Ang II receptor antagonists has been shown to restore normal blood pressure and normal renal hemodynamics in humans with essential hypertension, as well as in experimental rats with spontaneous hypertension, 20 with hypertension induced by chronic NOS inhibition, 16 and with renovascular hypertensive disease. 21 Our results suggests that, as in conventional vascular tissue, a relative increase in Ang II in the modi®ed vascular tissue of the corpus cavernosum may contribute to erectile dysfunction. Furthermore, such impaired relaxation and/or augmented contractility of the cavernosal smooth muscle may be amenable to treatment with agents that block the effect of Ang II (Ang II receptor antagonists) or impede the production of Ang II (ACE inhibitors).
Conclusion
Canine cavernosal tissue contracted in response to angiotensin II. This response was augmented by administration of a nitric oxide synthase inhibitor, and inhibited by a speci®c angiotensin II receptor antagnoist. Angiotensin II receptor blockade also signi®cantly inhibited the contractile response of the cavernosal tissue to electric ®eld stimulation and to the alpha-adrenergic agonist phenylephrine. Therefore angiotensin II plays an important role in cavernosal smooth muscle contraction in vitro. Furthermore, the contractile effect of Ang II on erectile tissue is modulated by local NO levels, as has been previously demonstrated in extracavernosal vascular smooth muscle.
